Total Payments
$7,617
2024 Payments
$534.08
Companies
23
Transactions
159
Medicare Patients
3,260
Medicare Billing
$389,315
Payment Breakdown by Category
Food & Beverage$7,507 (98.6%)
Education$109.93 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,507 | 157 | 98.6% |
| Education | $109.93 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,090 | 27 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $976.23 | 8 | $0 (2020) |
| PFIZER INC. | $943.96 | 40 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $845.79 | 9 | $0 (2019) |
| Allergan Inc. | $542.67 | 6 | $0 (2019) |
| Incyte Corporation | $505.05 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $400.38 | 20 | $0 (2024) |
| LEO Pharma Inc. | $345.35 | 5 | $0 (2018) |
| UCB, Inc. | $300.56 | 12 | $0 (2024) |
| Galderma Laboratories, L.P. | $289.20 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $534.08 | 9 | Incyte Corporation ($239.79) |
| 2023 | $434.08 | 11 | Lilly USA, LLC ($162.30) |
| 2022 | $645.96 | 28 | Lilly USA, LLC ($164.66) |
| 2021 | $249.14 | 15 | Lilly USA, LLC ($118.29) |
| 2020 | $405.96 | 10 | Janssen Scientific Affairs, LLC ($125.00) |
| 2019 | $1,781 | 34 | Ortho Dermatologics, a division of Bausch Health US, LLC ($542.17) |
| 2018 | $1,655 | 23 | LEO Pharma Inc. ($345.35) |
| 2017 | $1,911 | 29 | Janssen Scientific Affairs, LLC ($487.11) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $107.24 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Immunology | ||||||
| 06/27/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $132.55 | General |
| Category: Dermatology | ||||||
| 05/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: Immunology | ||||||
| 05/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology | ||||||
| 03/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 02/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Immunology | ||||||
| 02/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: Immunology | ||||||
| 12/21/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Immunology | ||||||
| 12/07/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.15 | General |
| 12/01/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Immunology | ||||||
| 11/27/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $118.89 | General |
| Category: Immunology | ||||||
| 10/18/2023 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Inflammation & Immunology | ||||||
| 08/16/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.37 | General |
| 04/20/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.89 | General |
| 03/29/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $125.88 | General |
| Category: Dermatology | ||||||
| 02/08/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 02/01/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Immunology | ||||||
| 12/15/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Immunology | ||||||
| 12/14/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Immunology | ||||||
| 12/14/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Immunology | ||||||
| 12/02/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $139.38 | General |
| Category: Dermatology | ||||||
| 11/23/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 815 | 2,555 | $152,939 | $106,644 |
| 2022 | 13 | 836 | 2,625 | $142,164 | $97,021 |
| 2021 | 16 | 931 | 2,804 | $165,598 | $119,782 |
| 2020 | 13 | 678 | 1,841 | $101,310 | $65,867 |
Total Patients
3,260
Total Services
9,825
Medicare Billing
$389,315
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 226 | 510 | $45,960 | $33,712 | 73.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 162 | 353 | $28,329 | $18,894 | 66.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 136 | 1,332 | $11,988 | $7,928 | 66.1% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 54 | $11,172 | $6,998 | 62.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $9,135 | $6,148 | 67.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 24 | $7,034 | $5,241 | 74.5% |
| 11441 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 27 | 30 | $6,254 | $4,295 | 68.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 41 | $5,337 | $3,762 | 70.5% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 12 | 15 | $4,815 | $3,629 | 75.4% |
| 11641 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 11 | 17 | $4,843 | $3,546 | 73.2% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 21 | 30 | $5,608 | $3,516 | 62.7% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2023 | 17 | 37 | $3,678 | $2,736 | 74.4% |
| 11442 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 13 | 15 | $3,345 | $2,341 | 70.0% |
| 11422 | Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $3,036 | $2,154 | 71.0% |
| 11421 | Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 12 | 13 | $2,405 | $1,745 | 72.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 236 | 487 | $43,829 | $31,315 | 71.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 165 | 364 | $29,821 | $20,143 | 67.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 148 | 1,414 | $12,690 | $8,474 | 66.8% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 34 | 46 | $9,667 | $6,429 | 66.5% |
| 11441 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 36 | 43 | $9,025 | $6,264 | 69.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 74 | 74 | $9,606 | $6,003 | 62.5% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 35 | 42 | $7,836 | $5,399 | 68.9% |
| 11442 | Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 18 | 24 | $5,352 | $3,712 | 69.4% |
| 11421 | Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2022 | 16 | 21 | $3,874 | $2,638 | 68.1% |
| 17250 | Application of chemical to stop tissue regrowth in wound | Office | 2022 | 18 | 40 | $3,924 | $2,613 | 66.6% |
About Dr. Douglas Altchek, M.D
Dr. Douglas Altchek, M.D is a Dermatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1366449340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Altchek, M.D has received a total of $7,617 in payments from pharmaceutical and medical device companies, with $534.08 received in 2024. These payments were reported across 159 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($7,507).
As a Medicare-enrolled provider, Altchek has provided services to 3,260 Medicare beneficiaries, totaling 9,825 services with total Medicare billing of $389,315. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location New York, NY
- Active Since 07/05/2005
- Last Updated 12/14/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366449340
Products in Payments
- EUCRISA (Drug) $875.16
- TALTZ (Drug) $726.04
- OPZELURA (Drug) $505.05
- SILIQ (Drug) $420.79
- STELARA (Biological) $408.09
- Tremfya (Drug) $391.33
- TREMFYA (Drug) $317.96
- Otezla (Drug) $265.00
- ACZONE (Drug) $249.68
- ENSTILAR (Drug) $224.11
- Bimzelx (Biological) $215.17
- EPIDUO FORTE (Drug) $202.17
- OLUMIANT (Drug) $160.95
- QBREXZA (Drug) $156.76
- DUOBRII (Drug) $150.00
- REMICADE (Biological) $135.71
- JUBLIA (Drug) $123.00
- PICATO (Drug) $121.24
- ALTRENO (Drug) $115.93
- FreeStyle Libre Pro (Device) $115.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in New York
David Cohen, M.d, M.D
Dermatology — Payments: $3.1M
Dermatology $3.1M
Dr. Amy Wechsler, M.d, M.D
Dermatology — Payments: $2.8M
Dermatology $2.8M
Dr. Alexandra Golant, M.d, M.D
Dermatology — Payments: $2.7M
Dermatology $2.7M
Emma Guttman, Md, MD
Dermatology — Payments: $2.2M
Dermatology $2.2M
Dr. Joshua Zeichner, Md, MD
Dermatology — Payments: $2.1M
Dermatology $2.1M
Dr. Mark Lebwohl
Dermatology — Payments: $2.0M
Dermatology $2.0M